The role of arterial hypertension in the progression of non-diabetic glomerular diseases

View Full Paper

Ask AI

Bookmark

Population

Patients with non-diabetic glomerular diseases and arterial hypertension

Design

Review

Authors

Discussion

Supports BP targets and ACEI preference in non-diabetic CKD; leaves open need for confirmatory RCTs.

Population

Patients with non-diabetic glomerular diseases and arterial hypertension

Intervention

Antihypertensive therapy (including ACE inhibitors, calcium channel blockers, and angiotensin II receptor blockers)

Outcome

Progression of chronic kidney disease

Strict blood pressure control, particularly with ACE inhibitors, is crucial for slowing the progression of non-diabetic chronic renal failure.

Dragan Ljutić (2003) studied this question.

View Full Paper

Ask AI

Bookmark